cbdMD, Inc. reported earnings results for the third quarter and nine months ended June 30, 2023. For the third quarter, the company reported sales was USD 6.46 million compared to USD 8.87 million a year ago. Revenue was USD 6.12 million compared to USD 8.59 million a year ago. Net loss was USD 1.77 million compared to USD 31.63 million a year ago. Basic loss per share from continuing operations was USD 1.16 compared to USD 24.81 a year ago. Diluted loss per share from continuing operations was USD 1.16 compared to USD 24.81 a year ago.
For the nine months, sales was USD 19.29 million compared to USD 28.67 million a year ago. Revenue was USD 18.44 million compared to USD 27.54 million a year ago. Net loss was USD 7.06 million compared to USD 55.45 million a year ago. Basic loss per share from continuing operations was USD 4.26 compared to USD 44.41 a year ago. Diluted loss per share from continuing operations was USD 4.26 compared to USD 44.41 a year ago.